The CDC42-specific inhibitor derived from ACK-1 blocks v-Ha-Ras-indnced transformation

Oncogene

Volumn 18, Issue 54, 1999, Pages 7787-7793

  Nur E Kamal, M S A ^a,b   Kamal, J M ^a,b   Qureshi, M M ^a   Maruta, H ^c  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

Author keywords

ACK; CDC42; Neurite outgrowth; NGF; Ras transformation; Tumor suppressor

Indexed keywords

CELL CYCLE PROTEIN; EPIDERMAL GROWTH FACTOR; GUANOSINE TRIPHOSPHATE; HYBRID PROTEIN; INHIBITOR PROTEIN; NERVE GROWTH FACTOR; PROTEIN TYROSINE KINASE; RAS PROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; CELL STRAIN; CELL STRAIN 3T3; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; FIBROBLAST; GENE ACTIVATION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE H RAS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN;

ANIMALIA;

EID: 0033576673     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203215     Document Type: Article

References (27)

1. Aramori I, Zenkoh J, Morikawa N, O'Donnell N, Asano M, Nakamura K, Iwami M, Kojo H and Notsu Y. (1997). Mol. Pharmacol., 51, 171-176.
2. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS and Bustelo XR. (1997). Nature, 385, 169-172.
3. De Rooji J and Bos JL. (1997). Oncogene, 14, 623-625.
4. Derossi D, Chassaing G and Prochiantz A. (1998). Trends Cell Biol., 8, 84-87.
5. Downward J, de Gunzburg J, Riehl R and Weinberg R. (1988). Proc. Natl. Acad. Sci. USA, 85, 5774-5778.
6. Feig L. (1999). Nature Cell Biol., 1, E25-E27.
7. Fridman M, Tikoo A, Varga M, Murphy A, Nur-E-Kamal MSA and Maruta H. (1994). J. Biol. Chem., 269, 30105-30108.
8. Hall A. (1998). Science, 279, 509-514.
9. Han J, Luby-Phelps K, Das B, Shu X, Xia Y, Mosteller RD, Krishna UM, Falck JR, White MA and Broek D. (1998). Science, 279, 558-560.
10. Kozma R, Ahmed S, Best A and Lim L. (1995). Mol. Cell. Biol., 15, 1942-1952.
11. Leblanc V, Tocque B and Delumeau I. (1998). Mol. Cell. Biol., 18, 5567-5578.
12. Lebowitz PF, Davide JP and Prendergast GC. (1995). Mol. Cell. Biol., 15, 6613-6622.
13. Manser E, Leung T, Salihuddin H, Tan L and Lim L. (1993). Nature, 363, 364-367.
14. Maruta H. (1996). In: Regulation of the RAS Signaling Network. Maruta H and Burgess AW. (eds), Springer-Verlag: Heidelberg, pp 139-180.
15. Maruta H. (1998). In: G Proteins, Cytoskeleton Cancer. Maruta H and Kohama K. (eds), R.G. Landes Bioscience: Austin, TX. pp 151-170.
16. Maruta H, Holden J, Sizeland A and D'Abaco G. (1991). J. Biol. Chem., 266, 11661-11668.
17. Miki H, Sasaki T, Takai Y and Tanekawa T. (1998). Nature, 391, 93-96.
18. Mott HR, Owen D, Nietlispatth D, Lowe P, Manser E, Lim L and Laue ED. (1999). Nature, 399, 384-388.
19. Nobes CD and Hall A. (1999). J. Cell Biol., 144, 1235-1244.
20. Nur-E-Kamal MSA, Sizeland A, D'Abaco G and Maruta H. (1992). J. Biol. Chem., 267, 1415-1418.
21. Qiu RG, Chen J, Kirn D, McCormick F and Symons M. (1995). Nature, 374, 457-459.
22. Qiu RG, Abo A, McCormick F and Symons M. (1997). Mol. Cell. Biol., 17, 3449-3458.
23. Rittinger K, Walker P, Ecclestone J, Nurmahomed K, Owen D, Laue E, Gamblin S and Smerdon S. (1997). Nature, 388, 693-697.
24. Rodriguez-Viciana P, Warne P, Khwaja A, Marte B, Das P, Waterfield M, Ridley A and Downward J. (1997). Cell, 89, 457-467.
25. Wang DZM, Nur-E-Kamal MSA, Tikoo A, Montague W and Maruta H. (1997). Cancer Res., 57, 2478-2484.
26. Williams E, Dunican D, Green P, Howell F, Derossi D, Walsh F and Doherty P. (1997). J. Biol. Chem., 272, 22349-22354.
27. Yang W and Cerione R. (1997). J. Biol. Chem., 272, 24810-24824.